About Aeras
Aeras is a company based in Gaithersburg (United States) founded in 2003 by Milan Vaclavik. Development of tuberculosis vaccines is undertaken by Aeras. Its chief executive, as recorded, is Milan Vaclavik. Its legal entity is InterWorx, Inc.
Company details
Aeras was founded in 2003 and is headquartered in Gaithersburg, United States. Focus is placed on the biotechnology sector, specifically the creation and advancement of vaccines targeting tuberculosis. Operations involve research and development efforts aimed at addressing global health challenges posed by TB. Collaboration with international partners is maintained to support vaccine trials and distribution in endemic regions. Leadership is provided by co-founder and CEO Milan Vaclavik.
- Latest Funding Round$852.95K (USD), Grant
Sep 2010
- Investors
Funding Insights of Aeras
- Total Rounds 2
- Last Round Grant — $852,950
- First Round $845,161
(Jul 2010)
- Investors Count 1
All 2 funding rounds of Aeras with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in Aeras
Aeras has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Aeras
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Aeras
5 people are tracked at Aeras (2 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Milan Vaclavik | Co-Founder & CEO | Leadership |
Thomas G. Evans | President & CEO | Leadership |
David McCown | Project Manager | Team |
Rosella Anstine | Project Coordinator | Team |
Rebecca Neill | Fellow In External Affairs | Team |
Complete people profiles for Aeras
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Aeras
3 dated milestones of Aeras across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Aeras is founded.
- Funding First funding round of $845K.
- Funding Latest funding round, Grant, of $853K.
Web traffic of Aeras
Websites that share an audience with Aeras (aeras.org).
Websites whose visitors overlap most with Aeras. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| geovax.com | 62% | 6.8K | #3,124,816 | View details | |
| vbivaccines.com | 61% | 11.4K | #3,481,567 | View details | |
| genocea.com | 60% | View details | |||
| indimmune.com | 59% | 16.1K | #1,365,274 | View details | |
| ichorms.com | 46% | 5.3K | #8,265,520 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Aeras
Aeras was founded in 2003 and raised its 1st funding round 7 years after it was founded.
Aeras is headquartered in Gaithersburg, United States. It is registered at Gaithersburg, Maryland, United States.
Milan Vaclavik is the CEO of Aeras, as recorded in our data. They have also founded this company.
Aeras was founded in 2003 and is headquartered in Gaithersburg, United States. Focus is placed on the biotechnology sector, specifically the creation and advancement of vaccines targeting tuberculosis. Operations involve research and development efforts aimed at addressing global health challenges posed by TB. Collaboration with international partners is maintained to support vaccine trials and distribution in endemic regions. Leadership is provided by co-founder and CEO Milan Vaclavik.
Aeras has 1 investor. Key investors include HHS.
Aeras operates through Interworx, Inc.